This review provides practical recommendations for managing type B aortic dissection in the era of endovascular therapies.
Stagnant survival despite publications signals caution with current strategies; leaves open whether novel therapies can improve long-term outcomes in type B aortic dissection.
Despite an unprecedented number of publications on all aspects of type B aortic dissections, it remains a formidable disease with barely changed long-term survival over the last decade. In this review, the bewildering amount of information is summarized to distill some practical recommendations for the practitioner faced with one of these patients in the era of endovascular approaches to the aorta.
No takes yet. Share an insight, caveat, or question.
Meisner et al. (2011) studied this question.